SEARCH

SEARCH BY CITATION

References

  • 1
    Hourani JM, Bellamy PE, Tashkin DP, Batra P, Simmons MS. Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity. Am J Med 1991; 90: 693700.
  • 2
    Eriksson LS, Soderman C, Ericzon BG, Eleborg L, Wahren J, Hadenstierna G. Normalization of ventilation/perfusion relationships after liver transplantation in patients with decompensated cirrhosis: evidence for a hepatopulmonary syndrome. HEPATOLOGY 1990; 12: 13501357.
  • 3
    Heinmann HO. Respiration and circulation in patients with portal cirrhosis of the liver. Circulation 1960; 22: 154159.
  • 4
    Rossing TH, Boixeda D, Maffeo N, Fencl V. Hyperventilation with hypoproteinemia. J Lab Clin Med 1988; 112: 553559.
  • 5
    Heinmann HO, Emirgil C, Mijnssen JP. Hyperventilation and arterial hypoxemia in cirrhosis of the liver. Am J Med 1960; 28: 239245.
  • 6
    Whitmore S, Chiodi H. Progesterone, pulmonary hyperventilation, and cirrhosis (Letter). Ann Intern Med 1972; 77: 326327.
  • 7
    Wilson WP, Malcolm PT. Electroencephalographic observations during experimental hyperammonemia. Neurology 1958; 2: 913916.
  • 8
    Furukawa T, Hara N, Yasumoto K, Inokuchi K. Arterial hypoxemia in patients with hepatic cirrhosis. Am J Med Sci 1984; 287: 1013.
  • 9
    Krowka MJ, Tajik J, Dickson ER, Wiesner RH, Cortese DA. Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Chest 1990; 97: 11651170.
  • 10
    Machida H. Influence of progesterone on arterial blood and CSF acid-base balance in women. J Appl Phys Res Env Exc Physiol 1981; 51: 14331436.
  • 11
    Skatrud JB, Dempsey JA, Kaiser DG. Ventilatory response to medroxyprogesterone acetate in normal subjects: time course and mechanism. J Appl Physiol Resp Env Exer Physiol 1978; 44: 939944.
  • 12
    Tatsumi K, Kimura H, Kunitomo F, Okita S, Tojima H, Yuguchi Y, Kuriyama T, et al. Effect of chlormadinone acetate on ventilatory control in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133: 552557.
  • 13
    Tatsumi K, Moore LG, Hannhat B. Influences of sex steroids on ventilation and ventilatory control. In: DempseyJA, PackAI, eds. Regulation of Breathing. New York: Dekker, 1995: 829864.
  • 14
    Hosenpud JD, Hart MV, Morton MJ, Hohimer AR, Resko JA. Progesterone-induced hyperventilation in the guinea pig. Respir Physiol 1983; 52: 259264.
  • 15
    MacLusky NJ, McEwen BS. Oestrogen modulates progestin receptor concentrations in some rat brain regions but not in others. Nature 1978; 274: 276278.
  • 16
    Child CG, Turcott J. The liver and portal hypertension. Ed 3. Philadelphia: Saunders, 1965.
  • 17
    Bayliss DA, Millhorn DE, Gallman EA, Bayliss DA, Millhorn DE, Gallman EA, Cidlowski JA, et al. Progesterone stimulates respiration through a central nervous system steroid receptor-mediated mechanism in cat. Proc Natl Acad Sci U S A 1987; 84: 77887792.
  • 18
    Bonekat HW, Dombovy ML, Stats BA. Progesterone-induced changes in exercise performance and ventilatory response. Med Sci Sports Exerc 1986; 19: 118123.
  • 19
    Brodeur P, Mockus M, McCullough R, Moore LG. Progesterone receptors and ventilatory stimulation by progestin. J Appl Physiol 1986; 60: 590595.
  • 20
    Hammond GL. Molecular properties of corticosteroid binding globulin and the sex-steroid binding proteins. Endo Rev 1990; 11: 6579.
  • 21
    Shaaban MM, Ghaneimah SA, Hammad WA, El-Sharkawy MM, Elwan SM, Ahmed YA. Sex steroids in women with liver cirrhosis. Int J Gynaecol Obstet 1980; 18: 181184.
  • 22
    Datta S, Hurley RJ, Naulty S, et al. Plasma and cerebrospinal fluid progesterone concentrations in pregnant and nonpregnant women. Anesth Analg 1986; 65: 950954.
  • 23
    Schwartz S, Pohl P. Steroid hormones and steroid hormone binding globulins in cerebrospinal fluid studied in individuals with intact and with disturbed blood-cerebrospinal fluid barrier. Neuroendocrinology 1992; 55: 174182.
  • 24
    Sumner BE. A quantatative study of vascular permeability to horseradish peroxidase, and the subsequent fate of the tracer, in rat brains after portocaval anastamosis. Neuropathol Appl Neurobiol 1982; 8: 117133.
  • 25
    Horowitz ME, Schafer DF, Molnar P, Jones EA, Blasberg RG, Patlak CS, Waggoner J, et al. Increased blood-brain transfer in a rabbit model of acute liver failure. Gastroenterology 1983; 84: 10031011.
  • 26
    McClung HJ, Sloan HR, Powers P, Merola AJ, Murray R, Kerzner B, Pollack D. Early changes in the permeability of the blood-brain barrier produced by toxins associated with liver failure. Pediatr Res 1990; 28: 227231.
  • 27
    Jones EA, Schafer DF, Ferenci P, Pappas SC. The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status. Yale J Biol Med 1984; 57: 301316.
  • 28
    Schafer DF. Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system. Lancet 1982; 1: 1820.
  • 29
    Basile AS, Hughes RD, Harrison PM, Murata Y, Pannell L, Jones A, Williams R, et al. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med 1991; 325: 473478.
  • 30
    Cohen JJ, Kassirer JP. Acid-base. Boston: Little, Brown, 1982: 235236.
  • 31
    Kitamura S, Yoshida T, Said SI. Vasoactive intestinal peptide: inactivation in liver and potentiation in lung of anesthetized dogs. Proc Soc Exp Biol Med 1975; 148: 2529.
  • 32
    Weil JV, Byrne-Quinn E, Sodal IE, Friesen WO, Underhill B, Filley GF, Grover RF. Hypoxic ventilatory drive in normal men. J Clin Inves 1970; 49: 10611072.
  • 33
    Weiss BD. RU 486. Arch Fam Med 1993; 2: 6370.
  • 34
    Baulieu EE, Ulmann A. Antiprogesterone activity of RU 486 and its con-tragestive and other applications. Hum Reprod 1986; 1: 107110.